Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Enzyme Replacement Therapy in Fabry Disease
JAMA 285:2743-2749, Schiffmann,R.,et al, 2001
See this aricle in Pubmed

Article Abstract
Fabry disease is a metabolic disorder without a specific treatment, caused by a deficiency of the lysosomal enzyme x-galactosidase A (x-gal A). Most patients experience debilitating neuropathic pain and premature mortality because of renal failure, cardiovascular disease, or cerebrovascular disease. Intravenous infusions of x-gal A are safe and have widespread therapeutic efficacy in Fabry disease.
 
Related Tags
(click to filter results - removes previous filter)

enzyme treatment
Fabry's disease
lipid storage disorder of CNS
neuropathic pain scale
neuropathy,painful
pain,neuropathic
treatment of neurologic disorder

Click Here to return To Results